Soft Tissue Tumor Pathology: An Anatomic and Pattern-Based Approach
December 10 - 11, 2016
Physicians Can Earn A Maximum Of 16 AMA PRA Category 1 Credits™
Physicians Can Earn A Maximum Of 12 SAM Credit Hours
Jason L. Hornick, MD, PhD
Harvard Medical School
Dr. Jason Hornick received a B.A. from Amherst College (Amherst, MA) and an M.D./Ph.D. from the University of Southern California (Los Angeles, CA). He trained as a resident in Anatomic Pathology and pursued subspecialty fellowships in soft tissue pathology and gastrointestinal pathology at Brigham and Women’s Hospital (Boston, MA), where he is now the Director of Surgical Pathology and Immunohistochemistry. He is a Professor of Pathology at Harvard Medical School and a consultant at the Dana Farber Cancer Institute.
Dr. Hornick is Chair of the USCAP (United States and Canadian Academy of Pathology) Education Committee, past Chair of the USCAP Abstract Review Board and Assignment Committee, and past Chair of the Immunohistochemistry Committee for the CAP (College of American Pathologists). He was a member of the consensus and editorial working group for the 4th edition of the WHO (World Health Organization) Classification of Tumors of Soft Tissue and Bone and currently serves as an expert member of the editorial board for the 5th edition. Dr. Hornick has also contributed to the WHO Classifications of Tumors of the Digestive System, Skin Tumors, Tumors of the Urinary System and Male Genital Organs, and Tumors of the Breast. He was a member of the Soft Tissue Sarcoma Expert Panel for the AJCC (American Joint Committee on Cancer) and a member of the Sarcoma Analysis Working Group for The Cancer Genome Atlas (TCGA). He also serves on the Test Development and Advisory Committee for Anatomic Pathology for the American Board of Pathology.
Dr. Hornick serves on 12 editorial boards, including Modern Pathology and the American Journal of Surgical Pathology. He is a Regional Editor for Histopathology, an Associate Editor for Advances in Anatomic Pathology, the Consulting Editor for Surgical Pathology Clinics, and on the Executive Advisory Board of Archives of Pathology and Laboratory Medicine. Dr. Hornick is the Associate Editor for the American Registry of Pathology (formerly AFIP) Atlases. Dr. Hornick has published around 400 original papers, review articles, and book chapters and edited the textbook Practical Soft Tissue Pathology: A Diagnostic Approach, the 2nd edition of which was recently published. He is an Associate Editor for Sternberg’s Diagnostic Surgical Pathology.
Dr. Hornick received the 2012 Arthur Purdy Stout Society of Surgical Pathologists Annual Prize and the 2014 Jack Yardley Investigator Award from the Gastrointestinal Pathology Society. He teaches courses on the diagnosis of soft tissue tumors, gastrointestinal pathology, and diagnostic immunohistochemistry.
Thomas Brenn, M.D., Ph.D., FRCPath
University of Calgary, Cumming School of Medicine
Dr. Brenn graduated magna cum laude from the Ruprecht-Karls University of Heidelberg (Heidelberg, Germany) where he received his MD and PhD degrees. After postdoctoral fellowships in the Departments of Genetics and Pathology at Stanford University (Stanford, CA, USA) and residency training in Anatomic Pathology at the Brigham and Women’s Hospital (Boston, MA, USA), he pursued subspecialty fellowships with Drs. Phillip McKee and Christopher Fletcher in Dermatopathology, Soft Tissue Tumor Pathology and Surgical Pathology. In 2003, Dr. Brenn joined the faculty of the Brigham and Women’s Hospital and Harvard Medical School and was a consultant in pathology at the Dana Farber Cancer Institute. From 2007 to 2018, he was Head of Dermatopathology at NHS Lothian University Hospitals Trust and Honorary Senior Lecturer at the University of Edinburgh (Edinburgh, Scotland). In 2018 he relocated to Canada where he was appointed Professor of Pathology & Laboratory Medicine at the Cumming School of Medicine, University of Calgary, Calgary, AB.
Dr. Brenn is a Diplomate of the American Board of Pathology (Anatomic Pathology) and Dermatology (Dermatopathology). He is Associate Editor for Histopathology and was the Chair of the Skin Working Group of the European Society of Pathology (ESP), Chief Examiner for the RCPath Diploma in Dermatopathology and a member of the steering committee of the National Specialist EQA scheme in Dermatopathology and of the executive committee of the British Society for Dermatopathology. He has contributed to major textbooks in Dermatology and Dermtopathology and is a co-editor of the 4th edition of McKee’s Pathology of the Skin. His clinical and research interests are in the areas of cutaneous soft tissue tumours, skin adnexal tumours as well as melanocytic tumour pathology.
Leona Doyle, M.D.
Brigham and Women’s Hospital
Dr. Doyle is an Assistant Professor at Harvard Medical School and Associate Pathologist in the Department of Pathology at Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston. Dr. Doyle did her medical training in Trinity College Dublin, Ireland, and commenced anatomic pathology training at St. James’s Hospital in Dublin before moving to the United States where she completed an Anatomic Pathology residency and Gastrointestinal and Soft Tissue Pathology fellowship training at Brigham and Women’s Hospital. Her research interests are primarily in soft tissue pathology, and she has authored numerous original articles, book chapters and review articles. Dr. Doyle has more recently served as teaching faculty within the USCAP, and has a strong interest in pathology education and training.
Brian Rubin, M.D., Ph.D.
Brian Rubin, M.D., Ph.D. is Professor of Pathology, Vice-Chair of Research within the Robert J. Tomsich Pathology and Laboratory Medicine Institute, and Director of Soft Tissue Pathology at the Cleveland Clinic. He received his Ph.D. in molecular biology and his M.D. from Cornell University Medical College. He did his residency in Anatomic Pathology at Brigham and Women’s Hospital and received fellowship training in soft tissue pathology, bone pathology, and cancer genetics.
Dr. Rubin has dedicated his career to a better understanding of the diagnosis and classification of soft tissue neoplasms, especially sarcomas, where he is a prominent figure nationally and internationally. He is widely regarded as a thought leader in the field and is a founding member of the International Society of Bone and Soft Tissue Pathology. His laboratory is focused on understanding the pathogenesis of sarcomas with the major aim of developing targeted therapies. Dr. Rubin has published over 150 peer reviewed journal articles and is the author of numerous reviews and book chapters. He was a member of the working group that authored the WHO Classification of Tumours of Bone and Soft Tissue in 2002 and 2013. He is well known for his work on gastrointestinal stromal tumor (GIST) and other cancers such as melanoma that are driven by oncogenically-activated KIT receptor tyrosine kinase. His group also characterized a novel gene fusion in epithelioid hemangioendothelioma (EHE), a sarcoma with endothelial differentiation. This latest development has allowed them to initiate studies of EHE biology with the goal of developing targeted therapies to treat EHE.